Eads & Heald Wealth Management Thermo Fisher Scientific Inc. Transaction History

Eads & Heald Wealth Management

  • $211 Million
  • Q3 2024

A detailed history of Eads & Heald Wealth Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Eads & Heald Wealth Management holds 4,475 shares of TMO stock, worth $2.3 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
4,475
Previous 4,709 4.97%
Holding current value
$2.3 Million
Previous $2.6 Million 6.3%
% of portfolio
1.31%
Previous 1.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$531.86 - $624.21 $124,455 - $146,065
-234 Reduced 4.97%
4,475 $2.77 Million
Q2 2024

Jul 23, 2024
SELL
$541.52 - $599.02 $25,451 - $28,153
-47 Reduced 0.99%
4,709 $2.6 Million
Q1 2024

Apr 23, 2024
SELL
$528.82 - $599.43 $150,184 - $170,238
-284 Reduced 5.63%
4,756 $2.76 Million
Q4 2023

Jan 30, 2024
SELL
$431.41 - $532.94 $12,942 - $15,988
-30 Reduced 0.59%
5,040 $2.68 Million
Q3 2023

Oct 27, 2023
SELL
$498.29 - $574.41 $61,289 - $70,652
-123 Reduced 2.37%
5,070 $2.57 Million
Q2 2023

Jul 25, 2023
SELL
$508.46 - $591.13 $140,843 - $163,743
-277 Reduced 5.06%
5,193 $2.71 Million
Q1 2023

Apr 21, 2023
SELL
$535.0 - $604.82 $31,565 - $35,684
-59 Reduced 1.07%
5,470 $3.15 Million
Q4 2022

Jan 27, 2023
BUY
$484.71 - $571.37 $8,724 - $10,284
18 Added 0.33%
5,529 $3.05 Million
Q3 2022

Oct 27, 2022
SELL
$507.19 - $604.49 $96,366 - $114,853
-190 Reduced 3.33%
5,511 $2.8 Million
Q2 2022

Jul 26, 2022
SELL
$500.9 - $612.21 $39,070 - $47,752
-78 Reduced 1.35%
5,701 $3.1 Million
Q1 2022

Apr 27, 2022
SELL
$524.0 - $644.92 $115,280 - $141,882
-220 Reduced 3.67%
5,779 $3.41 Million
Q4 2021

Jan 31, 2022
SELL
$569.0 - $667.24 $106,403 - $124,773
-187 Reduced 3.02%
5,999 $4 Million
Q3 2021

Oct 27, 2021
SELL
$509.53 - $609.78 $121,777 - $145,737
-239 Reduced 3.72%
6,186 $3.53 Million
Q2 2021

Jul 30, 2021
SELL
$441.0 - $508.24 $22,491 - $25,920
-51 Reduced 0.79%
6,425 $3.24 Million
Q1 2021

Apr 29, 2021
SELL
$439.85 - $518.83 $63,778 - $75,230
-145 Reduced 2.19%
6,476 $2.96 Million
Q4 2020

Feb 02, 2021
SELL
$435.06 - $527.66 $181,855 - $220,561
-418 Reduced 5.94%
6,621 $3.08 Million
Q3 2020

Nov 02, 2020
SELL
$359.77 - $441.52 $411,217 - $504,657
-1,143 Reduced 13.97%
7,039 $3.11 Million
Q2 2020

Jul 29, 2020
SELL
$275.2 - $362.34 $87,788 - $115,586
-319 Reduced 3.75%
8,182 $2.96 Million
Q1 2020

May 01, 2020
SELL
$255.3 - $340.05 $190,198 - $253,337
-745 Reduced 8.06%
8,501 $2.41 Million
Q4 2019

Jan 31, 2020
SELL
$271.93 - $328.04 $31,815 - $38,380
-117 Reduced 1.25%
9,246 $3 Million
Q3 2019

Oct 31, 2019
SELL
$268.46 - $305.43 $81,880 - $93,156
-305 Reduced 3.15%
9,363 $2.73 Million
Q2 2019

Jul 30, 2019
SELL
$257.51 - $295.55 $146,265 - $167,872
-568 Reduced 5.55%
9,668 $0
Q1 2019

Apr 26, 2019
SELL
$212.17 - $273.72 $95,688 - $123,447
-451 Reduced 4.22%
10,236 $0
Q4 2018

Jan 31, 2019
SELL
$208.47 - $251.98 $91,935 - $111,123
-441 Reduced 3.96%
10,687 $2.39 Million
Q3 2018

Oct 31, 2018
SELL
$205.57 - $244.32 $80,789 - $96,017
-393 Reduced 3.41%
11,128 $0
Q2 2018

Jul 27, 2018
SELL
$203.14 - $219.53 $29,658 - $32,051
-146 Reduced 1.25%
11,521 $0
Q1 2018

Apr 26, 2018
SELL
$192.98 - $224.11 $159,787 - $185,563
-828 Reduced 6.63%
11,667 $0
Q4 2017

Jan 31, 2018
SELL
$182.03 - $200.37 $17,656 - $19,435
-97 Reduced 0.77%
12,495 $0
Q3 2017

Oct 27, 2017
BUY
$171.74 - $194.04 $2.16 Million - $2.44 Million
12,592
12,592 $0

Others Institutions Holding TMO

# of Institutions
2,829
Shares Held
334M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Eads & Heald Wealth Management Portfolio

Follow Eads & Heald Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email